Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration

Clinical Chemistry

Volumn 44, Issue 3, 1998, Pages 606-613

  Ramamurthy, Narayanan ^a   Baliga, Narayan ^b   Wahr, Joyce A ^b   Schaller, Ulrich ^a   Yang, Victor C ^a   Meyerhoff, Mark E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTAMINE;

ARTICLE; AUTOMATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HEMATOCRIT; HUMAN; TITRIMETRY;

EID: 0031913953     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.3.606     Document Type: Article

References (23)

1. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997;43:1684-96.
2. Cohen EJ, Camerlengo LJ, Dearing JP. Activated clotting times and cardiopulmonary bypass: I. The effect of hemodilution and hypothermia upon activated clotting time. J Extra Corpor Technol 1980;12:139-41.
3. Culliford AT, Gitel NS, Starr N. Lack of correlation between activated clotting time and plasma heparin level during cardiopulmonary bypass. Ann Surg 1981;193:105-11.
4. Teien AN, Lie M, Abildgaard U. Assay of heparin in plasma using a chromogenic substrate for activated Factor X. Thromb Res 1976; 8:413-6.
5. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentrations in patients having cardiac operations. J Thorac Cardiovasc Surg 1994;108:1076-82.
6. Ma SC, Yang VC, Fu B, Meyerhoff ME. Electrochemical sensor for heparin: further characterization and bioanalytical applications. Anal Chem 1993;65:2078-84.
7. Meyerhoff ME, Fu B, Bakker E, Yun JH, Yang VC. Polyion-sensitive membrane electrodes for biomedical analysis. Anal Chem 1996; 68:168A-75A.
8. Yun JH, Meyerhoff ME, Yang VC. Protamine-sensitive polymer membrane electrode: characterization and bioanalytical applications. Anal Biochem 1995;224:212-20.
9. Fu B, Bakker E, Yun JH, Yang VC, Meyerhoff ME. Response mechanism of polymer membrane based potentiometric polyion sensors. Anal Chem 1994;66:2250-9.
10. Han IS, Ramamurthy N, Yun JH, Schaller U, Meyerhoff ME, Yang VC. Selective monitoring of peptidase activities with synthetic polypeptide substrates and polyion-sensitive membrane electrode detection. FASEB J 1996;10:1621-6.
11. Meyerhoff ME, Yang VC, Wahr JA, Lee LM, Yun JH, Fu B, et al. Potentiometric polyion sensors: new measurement technology for monitoring blood heparin concentrations during open heart surgery. Clin Chem 1995;41:1355-6.
12. Telting M, Collison ME, Meyerhoff ME. Simplified dual-lumen catheter design for simultaneous potentiometric monitoring of carbon dioxide and pH. Anal Chem 1994;66:576-83.
13. Sergeant EP. Potentiometry and potentiometric titrations. In: Kolthoff IM, Elwing PJ, eds. Chemical analysis, Vol. 69. New York: John Wiley and Sons, 1985:362-4.
14. Wahr JA, Yun JH, Yang VC, Lee LM, Fu B, Meyerhoff ME. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. J Cardiothorac Vasc Anesth 1996;10:447-50.
15. Bland MJ, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
16. Harrell JB, Jones AD, Choppin GR. A liquid ion-exchange membrane electrode for polyvalent ions. Anal Chem 1969;41:1459-62.
17. Martin CR, Freiser H. Response characteristics of ion-selective electrodes based on dinonylnaphthalenesulfonic acid. Anal Chem 1980;52:562-4.
18. Anderson JM, Marchant KK. Platelet interactions with biomaterials and artificial devices. CRC Crit Rev Biocompat 1985;1:111-204.
19. Yun JH, Ma SC, Fu B, Yang VC, Meyerhoff ME. Direct potentiometric membrane electrode measurements of heparin binding to macromolecules. Electroanalysis 1993;5:719-24.
20. Greiber S, Weber U, Galle J, Bramer P, Schollmeyer P. Activated clotting time is not a sensitive parameter to monitor anticoagulation with low molecular weight heparin in hemodialysis. Nephron 1997;76:15-9.
21. Carter CJ, Kelton JG, Hirsh J, Gent M. Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thromb Res 1981;21:169-74.
22. Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, et al. The impact of heparin concentration ana activated clotting time monitoring on blood conservation. J Thorac Cardiovasc Surg 1995;110:46-54.
23. Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, et al. More effective suppression of haemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentration rather than ACT. Thromb Haemost 1996;76:902-8.